Medicine and science in the fight against doping in sport

Medicine and science in the fight against doping in sport / D.H. Catlin, K.D. Fitch, A. Ljungqvist. – (Journal of Internal Medicine (2008) 264 (Aug) : p. 99-114)

  • DOI: 10.1111/j.1365-2796.2008.01993.x.

Content:

- Introduction

  • The IOC medical commission era
  • The WADA era

- Detection of doping substances and methods

  • Stimulants detection by gas chromatography Anabolic steroid detection by ummunoassay
  • Gas chromatography-mass spectrometry and liquid chromatography-mass spectrometry
  • Detection of testosterone and other endogenous steroids
  • Isotope-ratio mass spectrometry
  • Erythropoietins
  • Flow cytometry to detect blood doping
  • Human growth hormone
  • Profiling of blood or urine: longitudinal testing, passports and volunteer programs
  • Dietary supplements
  • Designer anabolic androgenic steroids
  • Rapidly deployed proactive methods

- Doping controls at Olympic games
- Therapeutic use of prohibited substances
- Conclusions



The fight against doping in sports commenced as a result of the death of a Danish cyclist during the Rome Olympic Games in 1960. The International Olympic Committee (IOC) established a Medical Commission (IOC-MC) which had the task of designing a strategy to combat the misuse of drugs in Olympic Sport. Some International Sport Federations (IF) and National Sports Federations followed suit, but progress was modest until the world's best male sprinter was found doped with anabolic steroids at the Olympic Games in Seoul in 1988. Further progress was made following the cessation of the cold war in 1989 and in 1999 public authorities around the world joined the Olympic Movement in a unique partnership by creating WADA, the 'World Anti-Doping Agency'. The troubled history of the anti-doping fight from the 1960s until today is reviewed. In particular, the development of detection methods for an ever increasing number of drugs that can be used to dope is described, as are the measures that have been taken to protect the health of the athletes, including those who may need banned substances for medical reasons.

Original document

Parameters

Science
Review
Date
1 August 2008
People
Catlin, Don H.
Fitch, Kenneth D.
Ljungqvist, Arne
Country
United States of America
Language
English
ADRV
Use / attempted use
Other organisations
International Olympic Committee (IOC)
World Anti-Doping Agency (WADA)
Analytical aspects
Mass spectrometry analysis
Testing method development
Doping classes
M1. Manipulation Of Blood And Blood Components
S1. Anabolic Agents
S2. Peptide Hormones, Growth Factors
S6. Stimulants
Substances
Erythropoietin (EPO)
Growth hormone (GH)
Testosterone
Medical terms
Blood doping
Endogenous substance
Therapeutic Use Exemption (TUE)
Various
Athlete Biological Passport (ABP)
BALCO affair
Doping control
Supplements
Document category
Scientific article
Document type
Pdf file
Date generated
9 May 2014
Date of last modification
10 March 2021
Category
  • Legal Source
  • Education
  • Science
  • Statistics
  • History
Country & language
  • Country
  • Language
Other filters
  • ADRV
  • Legal Terms
  • Sport/IFs
  • Other organisations
  • Laboratories
  • Analytical aspects
  • Doping classes
  • Substances
  • Medical terms
  • Various
  • Version
  • Document category
  • Document type
Publication period
Origin